Follow
Uwe Klaus Zettl
Uwe Klaus Zettl
University of Rostock, Department of Neurology
Verified email at med.uni-rostock.de - Homepage
Title
Cited by
Cited by
Year
Ocrelizumab versus Interferon Beta 1a in Relapsing Multiple Sclerosis
SL Hauser, A Bar-Or, G Comi
N Engl J Med 376, 221 - 234, 0
1807*
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
L Kappos, A Bar-Or, BAC Cree, RJ Fox, G Giovannoni, R Gold, ...
The Lancet 391 (10127), 1263-1273, 2018
9492018
Costs and quality of life in multiple sclerosis: a cross-sectional study in the United States
G Kobelt, J Berg, D Atherly, O Hadjimichael
Neurology 66 (11), 1696-1702, 2006
456*2006
Neuromyelitis optica: evaluation of 871 attacks and 1,153 treatment courses
I Kleiter, A Gahlen, N Borisow, K Fischer, KD Wernecke, B Wegner, ...
Annals of neurology 79 (2), 206-216, 2016
3872016
Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures
S Jarius, F Paul, D Franciotta, K Ruprecht, M Ringelstein, R Bergamaschi, ...
Journal of the neurological sciences 306 (1-2), 82-90, 2011
3772011
Animal models of multiple sclerosis—potentials and limitations
E Mix, H Meyer-Rienecker, HP Hartung, UK Zettl
Progress in neurobiology 92 (3), 386-404, 2010
2812010
Alemtuzumab CARE-MS II 5-year follow-up: efficacy and safety findings
AJ Coles, JA Cohen, EJ Fox, G Giovannoni, HP Hartung, E Havrdova, ...
Neurology 89 (11), 1117-1126, 2017
2772017
Disease-modifying therapies and infectious risks in multiple sclerosis
A Winkelmann, M Loebermann, EC Reisinger, HP Hartung, UK Zettl
Nature Reviews Neurology 12 (4), 217-233, 2016
2552016
Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)
HP Tony, G Burmester, H Schulze-Koops, M Grunke, J Henes, I Kötter, ...
Arthritis research & therapy 13, 1-14, 2011
2452011
Alemtuzumab CARE-MS I 5-year follow-up: durable efficacy in the absence of continuous MS therapy
E Havrdova, DL Arnold, JA Cohen, HP Hartung, EJ Fox, G Giovannoni, ...
Neurology 89 (11), 1107-1116, 2017
2312017
Apheresis therapies for NMOSD attacks: a retrospective study of 207 therapeutic interventions
I Kleiter, A Gahlen, N Borisow, K Fischer, KD Wernecke, K Hellwig, ...
Neurology: Neuroimmunology & Neuroinflammation 5 (6), e504, 2018
1942018
Longitudinal extensive transverse myelitis—it's not all neuromyelitis optica
C Trebst, P Raab, EV Voss, P Rommer, M Abu-Mugheisib, UK Zettl, ...
Nature Reviews Neurology 7 (12), 688-698, 2011
1872011
The cerebrospinal fluid in multiple sclerosis
F Deisenhammer, H Zetterberg, B Fitzner, UK Zettl
Frontiers in immunology 10, 438156, 2019
1772019
T-cell apoptosis in situ in experimental autoimmune encephalomyelitis following methylprednisolone pulse therapy
J Schmidt, R Gold, L Schönrock, UK Zettl, HP Hartung, KV Toyka
Brain 123 (7), 1431-1441, 2000
1762000
Macrophages in multiple sclerosis
W Brück, N Sommermeier, M Bergmann, U Zettl, HH Goebel, ...
Immunobiology 195 (4-5), 588-600, 1996
1691996
Neuroimaging in stroke recovery: a position paper from the First International Workshop on Neuroimaging and Stroke Recovery
H Christensen, L Derex, JB Pialat, M Wiart, N Nighoghossian, M Hermier, ...
Cerebrovascular diseases 18 (3), 260-267, 2004
1682004
CLIPPERS: chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids. Review of an increasingly recognized entity within the spectrum of …
A Dudesek, F Rimmele, S Tesar, S Kolbaske, PS Rommer, R Benecke, ...
Clinical & Experimental Immunology 175 (3), 385-396, 2014
1662014
Nabiximols (THC/CBD oromucosal spray, Sativex®) in clinical practice-results of a multicenter, non-interventional study (MOVE 2) in patients with multiple sclerosis spasticity
P Flachenecker, T Henze, UK Zettl
European neurology 71 (5-6), 271-279, 2014
1662014
Cognitive impairment in multiple sclerosis
A Winkelmann, C Engel, A Apel, UK Zettl
Journal of neurology 254, II35-II42, 2007
1642007
Multiple sclerosis and fatigue: a review on the contribution of inflammation and immune-mediated neurodegeneration
R Patejdl, IK Penner, TK Noack, UK Zettl
Autoimmunity reviews 15 (3), 210-220, 2016
1612016
The system can't perform the operation now. Try again later.
Articles 1–20